Cellosaurus logo
expasy logo

Cellosaurus AMOC-2 (CVCL_C830)

[Text][XML][JSON]
Cell line name AMOC-2
Synonyms AMOC2; Aichi Medical university Ovarian Carcinoma-2
Accession CVCL_C830
Resource Identification Initiative To cite this cell line use: AMOC-2 (RRID:CVCL_C830)
Comments Population: Japanese.
Characteristics: Established from a third generation xenograft established in BALB/c nu/nu mice.
Doubling time: 21.5-26.4 hours (PubMed=9433040).
Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
Disease Ovarian serous adenocarcinoma (NCIt: C7550)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Children:
CVCL_AT98 (AMOC-2 Subclone #10)CVCL_AT99 (AMOC-2 Subclone #11)CVCL_AT95 (AMOC-2 Subclone #2)
CVCL_AT96 (AMOC-2 Subclone #4)CVCL_AT97 (AMOC-2 Subclone #6)
Sex of cell Female
Age at sampling 60Y
Category Cancer cell line
Publications

PubMed=2794621
Hiromitsu Yabushita, Naoki Ueno, Keizo Sawaguchi, Kazuyoshi Higuchi, Masayoshi Noguchi, Minoru Ishihara;
Establishment and characterization of a new human cell-line (AMOC-2) derived from a serous adenocarcinoma of ovary.
Nihon Sanka Fujinka Gakkai Zasshi 41:888-894(1989)

PubMed=9433040; DOI=10.1111/j.1447-0756.1997.tb00878.x
Hiromitsu Yabushita, Masayoshi Noguchi, Masami Nakanishi;
Emergence of an irreversible differentiated subclone from the poorly differentiated ovarian adenocarcinoma cell line AMOC-2 treated with sodium butyrate.
J. Obstet. Gynaecol. Res. 23:493-502(1997)

Cross-references
Encyclopedic resources Wikidata; Q54749812
Entry history
Entry creation22-Oct-2012
Last entry update29-Jun-2023
Version number11